{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:13:12Z","timestamp":1792591992344,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,3,9]],"date-time":"2011-03-09T00:00:00Z","timestamp":1299628800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s10549-011-1431-4","type":"journal-article","created":{"date-parts":[[2011,3,8]],"date-time":"2011-03-08T11:16:28Z","timestamp":1299582988000},"page":"731-741","source":"Crossref","is-referenced-by-count":30,"title":["ADAM12 induces estrogen-independence in breast cancer cells"],"prefix":"10.1007","volume":"131","author":[{"given":"Roopali","family":"Roy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marsha A.","family":"Moses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,9]]},"reference":[{"issue":"16","key":"1431_CR1","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJMsr070105","volume":"356","author":"PM Ravdin","year":"2007","unstructured":"Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ, Edwards BK, Berry DA (2007) The decrease in breast-cancer incidence in 2003 in the united states. N Engl J Med 356(16):1670\u20131674. doi: 10.1056\/NEJMsr070105","journal-title":"N Engl J Med"},{"issue":"1","key":"1431_CR2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF00666205","volume":"32","author":"CK Osborne","year":"1994","unstructured":"Osborne CK, Fuqua SA (1994) Mechanisms of tamoxifen resistance. Breast Cancer Res Treat 32(1):49\u201355","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"1431_CR3","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1158\/0008-5472.CAN-09-1530","volume":"70","author":"K McCune","year":"2010","unstructured":"McCune K, Bhat-Nakshatri P, Thorat MA, Nephew KP, Badve S, Nakshatri H (2010) Prognosis of hormone-dependent breast cancers: implications of the presence of dysfunctional transcriptional networks activated by insulin via the immune transcription factor t-bet. Cancer Res 70(2):685\u2013696. doi: 10.1158\/0008-5472.CAN-09-1530","journal-title":"Cancer Res"},{"key":"1431_CR4","author":"S Masri","year":"2010","unstructured":"Masri S, Liu Z, Phung S, Wang E, Yuan YC, Chen S (2010) The role of microrna-128a in regulating TGFbeta signaling in letrozole-resistant breast cancer cells. Breast Cancer Res Treat. doi: 10.1007\/s10549-009-0716-3","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"1431_CR5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10549-008-0011-8","volume":"114","author":"T Frogne","year":"2009","unstructured":"Frogne T, Benjaminsen RV, Sonne-Hansen K, Sorensen BS, Nexo E, Laenkholm AV, Rasmussen LM, Riese DJ 2nd, de Cremoux P, Stenvang J, Lykkesfeldt AE (2009) Activation of ErbB3, EGFR and ERK is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant. Breast Cancer Res Treat 114(2):263\u2013275. doi: 10.1007\/s10549-008-0011-8","journal-title":"Breast Cancer Res Treat"},{"key":"1431_CR6","doi-asserted-by":"crossref","unstructured":"Sonne-Hansen K, Norrie IC, Emdal KB, Benjaminsen RV, Frogne T, Christiansen IJ, Kirkegaard T, Lykkesfeldt AE (2009) Breast cancer cells can switch between estrogen receptor alpha and erbb signaling and combined treatment against both signaling pathways postpones development of resistance. Breast Cancer Res Treat. doi: 10.1007\/s10549-009-0506-y","DOI":"10.1007\/s10549-009-0506-y"},{"issue":"2","key":"1431_CR7","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/ijc.24750","volume":"126","author":"SE Ghayad","year":"2009","unstructured":"Ghayad SE, Vendrell JA, Larbi SB, Dumontet C, Bieche I, Cohen PA (2009) Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K\/AKT signaling pathways. Int J Cancer 126(2):545\u2013562. doi: 10.1002\/ijc.24750","journal-title":"Int J Cancer"},{"issue":"5","key":"1431_CR8","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0002-9440(10)65403-X","volume":"154","author":"K Iba","year":"1999","unstructured":"Iba K, Albrechtsen R, Gilpin BJ, Loechel F, Wewer UM (1999) Cysteine-rich domain of human ADAM12 (meltrin alpha) supports tumor cell adhesion. Am J Pathol 154(5):1489\u20131501","journal-title":"Am J Pathol"},{"issue":"1","key":"1431_CR9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nm0102-35","volume":"8","author":"M Asakura","year":"2002","unstructured":"Asakura M, Kitakaze M, Takashima S, Liao Y, Ishikura F, Yoshinaka T, Ohmoto H, Node K, Yoshino K, Ishiguro H, Asanuma H, Sanada S, Matsumura Y, Takeda H, Beppu S, Tada M, Hori M, Higashiyama S (2002) Cardiac hypertrophy is inhibited by antagonism of adam12 processing of hb-egf: metalloproteinase inhibitors as a new therapy. Nat Med 8(1):35\u201340. doi: 10.1038\/nm0102-35nm0102-35[pii]","journal-title":"Nat Med"},{"issue":"2","key":"1431_CR10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ydbio.2005.05.004","volume":"283","author":"K Horiuchi","year":"2005","unstructured":"Horiuchi K, Zhou HM, Kelly K, Manova K, Blobel CP (2005) Evaluation of the contributions of adams 9, 12, 15, 17, and 19 to heart development and ectodomain shedding of neuregulins beta1 and beta2. Dev Biol 283(2):459\u2013471. doi: S0012-1606(05)00298-8[pii]10.1016\/j.ydbio.2005.05.004","journal-title":"Dev Biol"},{"issue":"1","key":"1431_CR11","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1074\/jbc.M605451200","volume":"282","author":"E Dyczynska","year":"2007","unstructured":"Dyczynska E, Sun D, Yi H, Sehara-Fujisawa A, Blobel CP, Zolkiewska A (2007) Proteolytic processing of delta-like 1 by adam proteases. J Biol Chem 282(1):436\u2013444. doi: 10.1074\/jbc.M605451200","journal-title":"J Biol Chem"},{"issue":"4","key":"1431_CR12","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.bbrc.2003.12.183","volume":"314","author":"N Ito","year":"2004","unstructured":"Ito N, Nomura S, Iwase A, Ito T, Kikkawa F, Tsujimoto M, Ishiura S, Mizutani S (2004) Adams, a disintegrin and metalloproteinases, mediate shedding of oxytocinase. Biochem Biophys Res Commun 314(4):1008\u20131013","journal-title":"Biochem Biophys Res Commun"},{"issue":"27","key":"1431_CR13","doi-asserted-by":"crossref","first-page":"16993","DOI":"10.1074\/jbc.273.27.16993","volume":"273","author":"F Loechel","year":"1998","unstructured":"Loechel F, Gilpin BJ, Engvall E, Albrechtsen R, Wewer UM (1998) Human adam 12 (meltrin alpha) is an active metalloprotease. J Biol Chem 273(27):16993\u201316997","journal-title":"J Biol Chem"},{"issue":"3","key":"1431_CR14","doi-asserted-by":"crossref","first-page":"511515","DOI":"10.1006\/bbrc.2000.3835","volume":"278","author":"F Loechel","year":"2000","unstructured":"Loechel F, Fox JW, Murphy G, Albrechtsen R, Wewer UM (2000) Adam 12-s cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3. Biochem Biophys Res Commun 278(3):511515. doi: 10.1006\/bbrc.2000.3835S0006-291X(00)93835-X[pii]","journal-title":"Biochem Biophys Res Commun"},{"issue":"49","key":"1431_CR15","doi-asserted-by":"crossref","first-page":"51323","DOI":"10.1074\/jbc.M409565200","volume":"279","author":"R Roy","year":"2004","unstructured":"Roy R, Wewer UM, Zurakowski D, Pories SE, Moses MA (2004) Adam 12 cleaves extracellular matrix proteins and correlates with cancer status and stage. J Biol Chem 279(49):51323\u201351330","journal-title":"J Biol Chem"},{"issue":"11","key":"1431_CR16","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1158\/0008-5472.CAN-05-0262","volume":"65","author":"M Kveiborg","year":"2005","unstructured":"Kveiborg M, Frohlich C, Albrechtsen R, Tischler V, Dietrich N, Holck P, Kronqvist P, Rank F, Mercurio AM, Wewer UM (2005) A role for adam12 in breast tumor progression and stromal cell apoptosis. Cancer Res 65(11):4754\u20134761. doi: 10.1158\/0008-5472.CAN-05-0262","journal-title":"Cancer Res"},{"issue":"9","key":"1431_CR17","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.biocel.2008.01.025","volume":"40","author":"M Kveiborg","year":"2008","unstructured":"Kveiborg M, Albrechtsen R, Couchman JR, Wewer UM (2008) Cellular roles of adam12 in health and disease. Int J Biochem Cell Biol 40(9):1685\u20131702. doi: 10.1016\/j.biocel.2008.01.025","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"1431_CR18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00432-004-0619-y","volume":"131","author":"U Lendeckel","year":"2005","unstructured":"Lendeckel U, Kohl J, Arndt M, Carl-McGrath S, Donat H, Rocken C (2005) Increased expression of adam family members in human breast cancer and breast cancer cell lines. J Cancer Res Clin Oncol 131(1):41\u201348. doi: 10.1007\/s00432-004-0619-y","journal-title":"J Cancer Res Clin Oncol"},{"issue":"24","key":"1431_CR19","doi-asserted-by":"crossref","first-page":"7359","DOI":"10.1158\/1078-0432.CCR-06-1066","volume":"12","author":"C Frohlich","year":"2006","unstructured":"Frohlich C, Albrechtsen R, Dyrskjot L, Rudkjaer L, Orntoft TF, Wewer UM (2006) Molecular profiling of adam12 in human bladder cancer. Clin Cancer Res 12(24):7359\u20137368. doi: 10.1158\/1078-0432.CCR-06-1066","journal-title":"Clin Cancer Res"},{"issue":"5","key":"1431_CR20","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0002-9440(10)63429-3","volume":"165","author":"T Kodama","year":"2004","unstructured":"Kodama T, Ikeda E, Okada A, Ohtsuka T, Shimoda M, Shiomi T, Yoshida K, Nakada M, Ohuchi E, Okada Y (2004) Adam12 is selectively overexpressed in human glioblastomas and is associated with glioblastoma cell proliferation and shedding of heparin-binding epidermal growth factor. Am J Pathol 165(5):1743\u20131753","journal-title":"Am J Pathol"},{"issue":"1","key":"1431_CR21","first-page":"17","volume":"26","author":"S Carl-McGrath","year":"2005","unstructured":"Carl-McGrath S, Lendeckel U, Ebert M, Roessner A, Rocken C (2005) The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer. Int J Oncol 26(1):17\u201324","journal-title":"Int J Oncol"},{"issue":"Suppl 1","key":"1431_CR22","first-page":"57","volume":"60","author":"J Markowski","year":"2009","unstructured":"Markowski J, Oczko-Wojciechowska M, Gierek T, Jarzab M, Paluch J, Kowalska M, Wygoda Z, Pfeifer A, Tyszkiewicz T, Jarzab B, Niedzielska I, Borgiel-Marek H (2009) Gene expression profile analysis in laryngeal cancer by high-density oligonucleotide microarrays. J Physiol Pharmacol 60(Suppl 1):57\u201363","journal-title":"J Physiol Pharmacol"},{"issue":"3","key":"1431_CR23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/jso.21313","volume":"100","author":"N Mino","year":"2009","unstructured":"Mino N, Miyahara R, Nakayama E, Takahashi T, Takahashi A, Iwakiri S, Sonobe M, Okubo K, Hirata T, Sehara A, Date H (2009) A disintegrin and metalloprotease 12 (adam12) is a prognostic factor in resected pathological stage i lung adenocarcinoma. J Surg Oncol 100(3):267\u2013272. doi: 10.1002\/jso.21313","journal-title":"J Surg Oncol"},{"issue":"5","key":"1431_CR24","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1053\/jhep.2003.50205","volume":"37","author":"H Le Pabic","year":"2003","unstructured":"Le Pabic H, Bonnier D, Wewer UM, Coutand A, Musso O, Baffet G, Clement B, Theret N (2003) Adam12 in human liver cancers: Tgf-beta-regulated expression in stellate cells is associated with matrix remodeling. Hepatology 37(5):1056\u20131066. doi: 10.1053\/jhep.2003.50205S0270913903002544[pii]","journal-title":"Hepatology"},{"issue":"5","key":"1431_CR25","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1158\/1055-9965.EPI-07-0365","volume":"17","author":"SE Pories","year":"2008","unstructured":"Pories SE, Zurakowski D, Roy R, Lamb CC, Raza S, Exarhopoulos A, Scheib RG, Schumer S, Lenahan C, Borges V, Louis GW, Anand A, Isakovich N, Hirshfield-Bartek J, Wewer U, Lotz MM, Moses MA (2008) Urinary metalloproteinases: Noninvasive biomarkers for breast cancer risk assessment. Cancer Epidemiol Biomarkers Prev 17(5):1034\u20131042. doi: 10.1158\/1055-9965.EPI-07-0365","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1431_CR26","doi-asserted-by":"crossref","unstructured":"Roy R BD, Rodig S, Moses M (2010) Adam12 long and short isoforms promote breast tumor growth and metastasis via distinct mechanisms [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; Apr 17\u201321; Washington, DC Philadelphia (PA) Abstract nr 416","DOI":"10.1158\/1538-7445.AM10-416"},{"issue":"34","key":"1431_CR27","doi-asserted-by":"crossref","first-page":"14536","DOI":"10.1073\/pnas.0907560106","volume":"106","author":"KR Coser","year":"2009","unstructured":"Coser KR, Wittner BS, Rosenthal NF, Collins SC, Melas A, Smith SL, Mahoney CJ, Shioda K, Isselbacher KJ, Ramaswamy S, Shioda T (2009) Antiestrogen-resistant subclones of MCF-7 human breast cancer cells are derived from a common monoclonal drug-resistant progenitor. Proc Natl Acad Sci USA 106(34):14536\u201314541. doi: 10.1073\/pnas.0907560106","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"1431_CR28","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1210\/en.2002-220620","volume":"144","author":"JM Knowlden","year":"2003","unstructured":"Knowlden JM, Hutcheson IR, Jones HE, Madden T, Gee JM, Harper ME, Barrow D, Wakeling AE, Nicholson RI (2003) Elevated levels of epidermal growth factor receptor\/c-erbb2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant mcf-7 cells. Endocrinology 144(3):1032\u20131044","journal-title":"Endocrinology"},{"issue":"11","key":"1431_CR29","first-page":"2099","volume":"3","author":"M Bos","year":"1997","unstructured":"Bos M, Mendelsohn J, Kim YM, Albanell J, Fry DW, Baselga J (1997) Pd153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number-dependent manner. Clin Cancer Res 3(11):2099\u20132106","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1431_CR30","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1074\/jbc.M706287200","volume":"283","author":"N Eckstein","year":"2008","unstructured":"Eckstein N, Servan K, Girard L, Cai D, von Jonquieres G, Jaehde U, Kassack MU, Gazdar AF, Minna JD, Royer HD (2008) Epidermal growth factor receptor pathway analysis identifies amphiregulin as a key factor for cisplatin resistance of human breast cancer cells. J Biol Chem 283(2):739\u2013750. doi: 10.1074\/jbc.M706287200","journal-title":"J Biol Chem"},{"issue":"12","key":"1431_CR31","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1210\/en.2002-220561","volume":"143","author":"RM Adam","year":"2002","unstructured":"Adam RM, Kim J, Lin J, Orsola A, Zhuang L, Rice DC, Freeman MR (2002) Heparin-binding epidermal growth factor-like growth factor stimulates androgen-independent prostate tumor growth and antagonizes androgen receptor function. Endocrinology 143(12):4599\u20134608","journal-title":"Endocrinology"},{"issue":"1","key":"1431_CR32","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1023\/A:1006232830161","volume":"58","author":"SS Larsen","year":"1999","unstructured":"Larsen SS, Egeblad M, Jaattela M, Lykkesfeldt AE (1999) Acquired antiestrogen resistance in mcf-7 human breast cancer sublines is not accomplished by altered expression of receptors in the erbb-family. Breast Cancer Res Treat 58(1):41\u201356","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"1431_CR33","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/1097-0215(20000815)87:4<487::AID-IJC5>3.0.CO;2-J","volume":"87","author":"A Fazio de","year":"2000","unstructured":"de Fazio A, Chiew YE, Sini RL, Janes PW, Sutherland RL (2000) Expression of c-erbb receptors, heregulin and oestrogen receptor in human breast cell lines. Int J Cancer 87(4):487\u2013498. doi: 10.1002\/1097-0215(20000815)87:4<487:AID-IJC5>3.0.CO;2-J","journal-title":"Int J Cancer"},{"issue":"6","key":"1431_CR34","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/j.1365-2184.2008.00557.x","volume":"41","author":"N Rocks","year":"2008","unstructured":"Rocks N, Estrella C, Paulissen G, Quesada-Calvo F, Gilles C, Gueders MM, Crahay C, Foidart JM, Gosset P, Noel A, Cataldo DD (2008) The metalloproteinase adam-12 regulates bronchial epithelial cell proliferation and apoptosis. Cell Prolif 41(6):988\u20131001. doi: 10.1111\/j.1365-2184.2008.00557.x","journal-title":"Cell Prolif"},{"issue":"3","key":"1431_CR35","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/art.23262","volume":"58","author":"A Okada","year":"2008","unstructured":"Okada A, Mochizuki S, Yatabe T, Kimura T, Shiomi T, Fujita Y, Matsumoto H, Sehara-Fujisawa A, Iwamoto Y, Okada Y (2008) Adam-12 (meltrin alpha) is involved in chondrocyte proliferation via cleavage of insulin-like growth factor binding protein 5 in osteoarthritic cartilage. Arthritis Rheum 58(3):778\u2013789. doi: 10.1002\/art.23262","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1431_CR36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1023\/A:1009511131541","volume":"5","author":"TL Wood","year":"2000","unstructured":"Wood TL, Richert MM, Stull MA, Allar MA (2000) The insulin-like growth factors (IGFs) and IGF binding proteins in postnatal development of murine mammary glands. J Mammary Gland Biol Neoplasia 5(1):31\u201342","journal-title":"J Mammary Gland Biol Neoplasia"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-011-1431-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-011-1431-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-011-1431-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T00:40:30Z","timestamp":1560040830000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-011-1431-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,9]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["1431"],"URL":"https:\/\/doi.org\/10.1007\/s10549-011-1431-4","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,9]]}}}